Condensed Consolidated and Combined Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	6 Months Ended
	Jun. 30, 2025	Jun. 30, 2024
Operating activities
Net income	$ 470.2	$ 216.1
Less: Income from discontinued operations, net of tax	276.5	37.7
Net income from continuing operations	193.7	178.4
Adjustments to reconcile net income from continuing operations to net cash provided by (used for) operating activities of continuing operations
Depreciation	28.2	24.8
Amortization	64.1	39.9
Deferred income taxes	2.0	0.1
Share-based compensation	20.1	12.7
Changes in assets and liabilities, net of effects of business acquisitions
Accounts and notes receivable	(152.8)	(10.4)
Inventories	(23.0)	(9.0)
Other current assets	28.3	(7.6)
Accounts payable	22.9	(8.1)
Employee compensation and benefits	0.8	(22.6)
Other current liabilities	(30.8)	(33.6)
Other non-current assets and liabilities	1.4	1.1
Net cash provided by (used for) operating activities of continuing operations	154.9	165.7
Net cash provided by (used for) operating activities of discontinued operations	(111.6)	55.1
Net cash provided by (used for) operating activities	43.3	220.8
Investing activities
Capital expenditures	(38.0)	(31.8)
Proceeds from sale of property and equipment	1.6	0.3
Acquisitions, net of cash acquired	(971.6)	0.0
Net cash provided by (used for) investing activities of continuing operations	(1,008.0)	(31.5)
Net cash provided by (used for) investing activities of discontinued operations	1,584.6	(2.8)
Net cash provided by (used for) investing activities	576.6	(34.3)
Financing activities
Net receipts of revolving credit facility	200.0	0.0
Proceeds from long-term debt	275.0	0.0
Repayments of long-term debt	(866.3)	(15.0)
Debt issuance costs	(1.9)	(2.7)
Dividends paid	(65.7)	(63.6)
Shares issued to employees, net of shares withheld	(2.0)	(1.9)
Repurchases of ordinary shares	(253.1)	0.0
Net cash provided by (used for) financing activities	(714.0)	(83.2)
Effect of exchange rate changes on cash and cash equivalents	30.0	(14.4)
Change in cash and cash equivalents	(64.1)	88.9
Cash and cash equivalents, beginning of period	131.2	179.6
Cash and cash equivalents within assets held for sale, beginning of period	58.7	5.5
Less: Cash and cash equivalents within assets held for sale, end of period	0.0	7.7
Cash and cash equivalents, end of period	$ 125.8	$ 266.3